Enhancement of platelet function by superoxide anion

Area of Science:

• Biochemistry
• Hematology
• Cell Biology

Background:

• Xanthine oxidase catalyzes the aerobic conversion of xanthine to uric acid, producing reactive oxygen species like superoxide anion.
• Reactive oxygen species, particularly superoxide anion, are implicated in various cellular processes and pathological conditions.

Purpose of the Study:

• To investigate the role of superoxide anion in xanthine oxidase-induced human platelet aggregation and serotonin release.
• To elucidate the mechanisms and modulators of superoxide-dependent platelet activation.

Main Methods:

• Washed human platelets were incubated with xanthine and xanthine oxidase.
• Platelet aggregation and [14C]serotonin release were measured.
• The effects of superoxide dismutase, catalase, mannitol, EDTA, prostaglandin E1, dibutyryl cyclic AMP, acetylsalicylic acid, and indomethacin were assessed.
• Intraplatelet 51Cr efflux and malonyldialdehyde production were also monitored.

Main Results:

• Xanthine and xanthine oxidase induced platelet aggregation and serotonin release in a dose- and time-dependent manner.
• These effects were inhibited by superoxide dismutase, indicating a role for superoxide anion.
• Superoxide-dependent release was modulated by EDTA, prostaglandin E1, and dibutyryl cyclic AMP.
• Prolonged incubation led to 51Cr efflux, prevented by catalase, suggesting oxidative damage.
• No significant malonyldialdehyde production was observed.

Conclusions:

• Superoxide anion is a key mediator of xanthine oxidase-induced platelet aggregation and serotonin release.
• These findings suggest a potential physiological role for superoxide-dependent platelet activation in hemostasis, especially in inflammatory conditions or vessel injury.
• Platelet responses to superoxide anion can be modulated by various signaling pathways and agents.